One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Issue Highlights page
doi : 10.1016/S0360-3016(22)00108-0
Volume 112, Issue 5, 1 April 2022, Pages A8-A10
Fast and Furious: New Data Examining Accelerated Radiation Therapy for Limited-Stage Small Cell Lung Cancer
CliffordRobinsonMD*Timothy J.KruserMD†DawnOwenMD, PhD‡JosephSalamaMD§Megan E.DalyMD||
Controversy of Adjuvant Locoregional Therapy for Node-Positive Anal Mucosal Melanoma
Stephanie K.SchaubMDEdward Y.KimMD
The Goldilocks Spot for Radiation Therapy in Anorectal Melanoma: Yes to the Primary Site After Local Excision; No to the Groin
B. AshleighGuadagnoloMD, MPH
Defer Dissection: Radiation Therapy and Systemic Therapy
MeriemMokhtechMDKimberly L.JohungMD, PhD
Locoregional-Directed Therapy Is Still a Cornerstone of Anorectal Melanoma Management
DevaratiMitraMD, PhD
Understanding the Differences Between Bayesian and Frequentist Statistics
IsabellaFornacon-WoodMRes*HiteshMistryPhD*CorinneJohnson-HartPhD†CorinneFaivre-FinnPhD*‡James P.B.O'ConnorPhD*§Gareth J.PricePhD*â€
A Survey to Assess and Delineate Approaches to Medical Student Outreach to Promote Diversity at Academic Radiation Oncology Programs
Malcolm D.MattesMD*CurtilandDeville JrMDâ€
Delivery of Adjuvant Radiation in 5 Days or Less After Lumpectomy for Breast Cancer: A Systematic Review
FrankViciniMD*JamesBroughmanMD†AhmedHalimaMD†ZacharyMayoMD†ElizabethObiBS†ZahraaAl-HilliMD‡DouglasArthurMD§DavidWazerMD§|ChiragShahMDâ€
Ten-Year Outcomes of Hypofractionated Postmastectomy Radiation Therapy of 26 Gy in 6 Fractions
FabienMignotMD, MSc*LaurentQueroMD, PhD*SophieGuillermMD*BethsabéeBenadonMD*MounaLabidiMD*CarolineCuvierMD†SylvieGiacchettiMD†HenriLorphelinMD‡LaurenceCahen-DoidyMD‡LuisTeixeiraMD, PhD†MarcEspieMD, PhD†ChristopheHennequinMD, PhD*
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
JuanitaCrookMD, FRCPC*Joseph P.RodgersMS†Thomas M.PisanskyMD‡Edouard J.TrabulsiMD§Mahul B.AminMD‖WilliamBicePhD¶GerardMortonMD#Albert D.MurthaMD��EricVigneaultMD, MSc††JoelleHelouMD, MSc‡‡Jeff M.MichalskiMD, MBA, FASTRO§§MackRoachIIIMD, FACR, FASTRO‖‖DavidBeyerMD¶¶Ashesh B.JaniMD, MSEE, FASTRO##Eric M.HorwitzMD, FABS, FASTRO���AdamRabenMD†††StephaniePughPhD†HowardSandlerMD‖‖‖
Prostate Cancer Patients to Reap the Benefits of “Seeds� Planted by NRG Oncology/RTOG 0526
NilujaThiruthaneeswaranMBBS, PhD*†Sandra L.TurnerMBBS, PhD*â€
Patterns of Prostate Cancer Recurrence After Brachytherapy Determined by Prostate-Specific Membrane Antigen–Positron Emission Tomography and Computed Tomography Imaging
SrinivasRamanMDâ�ŽMiraKeyesMD, FRCPCâ�ŽJustinOhMDâ�ŽEtienneRousseauMD†AndraKrauzeMDâ�ŽDonWilsonMD†FrançoisBénardMDâ€
Impact of Local Recurrence on Cause-Specific Death After Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Dynamic Prediction Using Landmark Model
KazuhitoUekiMD�YukinoriMatsuoMD, PhD�AtsuyaTakedaMD, PhD†SatoshiMoritaPhD‡MasatakaTaguriPhD§NorikoKishiMD�HidekiHanazawaMD�YuichiroTsurugaiMD, PhD†TakashiMizowakiMD, PhD�
Acute and Late Esophageal Toxicity After SABR to Thoracic Tumors Near or Abutting the Esophagus
Quaovi H.SodjiMD, PhD*†RyanKoBS*Rievon EybenMS*Susan G.OwenMS, BSN, RNâ�ŽDante P.I.CapaldiPhD*KarlBushPhD*Michael S.BinkleyMD, MS*†FahadAlrowaisMD*BillPickthornMS*Peter G.MaximPhD‡Michael F.GensheimerMD*†MaximilianDiehnMD, PhDâ�Žâ€ Billy W.LooJrMD, PhD*â€
Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis
YuWangMD*#TaoZhangMD*#YilinHuangMS†WeiLiMD*JingjingZhaoPhD*YinYangMD*CanjunLiMD*LuhuaWangMD‡NanBiPhD, MD�
Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer
LiLiMD�†1ShanshanTangMD�†1Jiani C.YinPhD‡LihuaDongMD, PhD§ZheYangMD║YuepingLiuMD#JieMaMD��PengyuChangMD, PhD§JiaohuiPangMSc‡HuaBaoPhD‡DianbinMuMD††XiaoliZhengMD, PhD‡‡ReyidaAishajiangMD§KewenHeMD�†ShaotongZhangMD§§MengNiMD*XueWuPhD‡XiaonanWangPhD‡…ShuanghuYuanMD, PhD�†‡‡
Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study
StéphanieSmetMD*†SofiaSpampinatoPhD‡RichardPötterMD§Ina M.Jürgenliemk-SchulzMD, PhD║Remi A.NoutMD, PhD¶#CyrusChargariMD, PhD��UmeshMahantshettyMD††‡‡AlinaSturdzaMD, FRCPC§BarbaraSegedinMD, PhD§§║║KjerstiBruheimMD, PhD¶¶PeterHoskinMD, FRCR##BhavanaRaiMD, DNB���FleurHuangMD†††RachelCooperMD, FRCR‡‡‡ElzbietaVan der Steen-BanasikMD§§§MaritSundsetMD║║║ErikVan LimbergenMD, PhD¶¶¶Li TeeTanMD����…KathrinKirchheinerMSc, PhD§
Pseudoprogression Is Frequent After Front-Line Radiation Therapy in Pediatric Low-Grade Glioma: Results From the German Low-Grade Glioma Cohort
AnnikaStockMD*†Caroline-ViktoriaHanckenMD*DanielaKandelsMD‡Rolf-DieterKortmannMD§StefanDietzschMD§BeateTimmermannMD||TorstenPietschMD¶BrigitteBisonMD*†ReneSchmidt#MirkoPhamMD*Astrid KatharinaGnekowMD‡MonikaWarmuth-MetzMD*â€
Quality of Life After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases
Bart J.PielkenroodMD*RoxanneGalPhD*NicolienKaspertsMD†Joost J.C.VerhoeffMD, PhD†Marcia M.T.J.BartelsMD*EnricaSeravalliPhD†Yvette M.van der LindenMD, PhD‡Evelyn M.MonninkhofPhD§Jorrit-JanVerlaanMD, PhD||Joanne M.van der VeldenMD, PhD†Helena M.VerkooijenMD, PhD*
Golgi Phosphoprotein 3 Confers Radioresistance via Stabilizing EGFR in Lung Adenocarcinoma
GuodongChenPhD*†PeizhongKongPhD*†MiaomiaoYangMSc*‡§WanglaiHuPhD||Kevin M.PrisePhD¶K.N.YuPhD#��ShujunCuiMSc*‡FengQinMSc*‡GangMengPhD§††Waleed AbdelbagiAlmahiMSc*‡LiliNieMSc*†WeiHanPhD*†‡‡
Low Expression of ECT2 Confers Radiation Therapy Resistance Through Transcription Coupled Nucleolar DNA Damage Repair
YanfangQiuPhD�†1WenfengHuPhD�†1MingWenPhD�†‡§║WenchaoZhaoPhD�†JinruXieMD�†JiaoZhangMD�†MengWangMD�†HanghangLiMD�†YajieZhaoPhD�ShujunFuPhD�†ZhuoxianRongPhD�†MianfengYaoPhD#YumeiDuanPhD��JunHuangPhD††YiWangPhD‡‡JunQinPhD‡‡HuiWangPhD§§Lun-QuanSunPhD�†‡§║RongTanPhD�†‡§║║║
Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation
Shi-SuoDuMD, PhD�1Gen-WenChenPhD�1PingYangMD�Yi-XingChenMD�YongHuPhD�Qian-QianZhaoPhD�YangZhangPhD�RongLiuMD†Dan-XueZhengMS�JianZhouMD, PhD‡JiaFanMD, PhD‡Zhao-ChongZengMD, PhD�
miR-142a-3p Enhances FlaA N/C Protection Against Radiation-Mediated Intestinal Injury by Modulating the IRAK1/NF-κB Signaling Pathway
TengLiuMDâ�Žâ€ Dong-mingWuMDâ�Žâ€ FengZhangMDâ�Žâ€ TingZhangMDâ�Žâ€ MiaoHeMDâ�Žâ€ Yang-yangZhaoMDâ�ŽJinLiMDâ�ŽLiLiMDâ�ŽYingXuPhDâ�Žâ€
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns
MartinGlasMD*Matthew T.BalloMD†Ze'evBomzonPhD‡NoaUrmanMSc‡ShayLeviBSc‡GititLavy-ShahafPhD‡SuriyaJeyapalanMD, MPH§Terence T.SioMD, MS||Paul M.DeRoseMD¶MartinMischMD#SophieTaillibertMD��ZviRamMD††Andreas F.HottingerMD, PhD‡‡JacobEasawMD§§Chae-YongKimMD, PhD||||SuyashMohanMD, PDCC¶¶RogerStuppMD##
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns
YiLaoPhD*DanRuanPhD*AprilVassantachartMD†ZhaoyangFanPhD‡Jason C.YeMD†Eric L.ChangMD†RobertChinMD, PhD*TaniaKaprealianMD*GabrielZadaMD, MS§Mark S.ShiroishiMD‡KeShengPhD*WenshaYangPhDâ€
In Regard to Mutter et al.
HenkStruikmansMD, PhDMirjam E.MastMSc, PhDAnna L.PetoukhovaPhDPhilip M.PoortmansMD, PhD
In Reply to Struikmans et al.
Robert W.MutterMDJ. IsabelleChoiMDRachel B.JimenezMDYoulia M.KirovaMDMarcioFagundesMDBruce G.HafftyMDRichard A.AmosMSc, FIPEMJulie A.BradleyMDPeter Y.ChenMDXuanfengDingPhDAntoinette M.CarrMDLeslie M.TaylorBSN, RNMarkPankuchPhDRaymond B. MailhotVegaMD, MPHAlice Y.HoMDPetra WittNyströmMD, PhDLisa A.McGeeMDJames J.UrbanicMD…Shannon M.MacDonaldMD
In Reply to Sari and Yazici
Roel J.H.M.SteenbakkersMD, PhDMaria I.van Rijn-DekkerMDMonique A.StokmanPhDRoel G.J.KierkelsPhDArjenvan der SchaafPhDJohanna G.M.van den HoekMDHendrik P.BijlMD, PhDMaria C.A.KramerMD, PhDRob P.CoppesPhDJohannes A.LangendijkMD, PhDPetervan LuijkPhD
Early Toxicity and Patient Reported Outcomes From a Phase 2 Trial of FDG-PET Response-Based De-Escalated Definitive Radiotherapy for p16+ Oropharynx Cancer
S.G.Allen1B.S.Rosen1M.P.Aryal1Y.Cao1M.Schipper2K.Casper3S.B.Chinn3K.Malloy3M.E.Prince3A.J.Rosko3A.Shuman3M.Spector3C.L.Stucken3P.L.Swiecicki4F.Worden4J.C.Brenner3D.A.Elliott1C.Schonewolf1…M.L.Mierzwa1
Non-Inferiority Margin and Nodal Analysis of De-Escalated Adjuvant Radiation Therapy (DART) for HPV-Related Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Preplanned Pooled Analysis of MC1273 & MC1675
D.J.Ma1K.Price2E.J.Moore3S.H.Patel4M.L.Hinni5B.Fruth6N.R.Foster6K.Van Abel3L.X.Yin7M.A.Neben-Wittich8Y.Garces9L.A.McGee10J.C.Rwigema11D.M.Routman8S.C.Lester8D.L.Price7J.R.Janus12A.V.Chintakuntlawar2…R.L.Foote9
Detection of Occult Recurrence Using Circulating HPV Tumor DNA Among Patients Treated for HPV-driven Oropharyngeal Squamous Cell Carcinoma
B.Berger1G.J.Hanna2M.Posner34E.Genden5C.Del Vecchio Fitz1S.P.Naber1C.Kuperwasser1
Kinetics of Circulating Human Papillomavirus (cHPV) DNA in Plasma and Oral Gargles From Patients with HPV-Positive Oropharyngeal Cancer (OPC) Treated with Definitive Radiation Therapy
M.Echevarria1C.H.Chung2A.Giuliano3R.Slebos2G.Q.Yang4P.J.Stevens5J.J.Caudell6
A Clinically Translatable, Extensively Validated Immune-based Classification of Human Papillomavirus-Associated Head and Neck Cancer With Implications for Treatment Deintensification and Immunotherapy
P.Zeng12M.Cecchini2J.Barrett1M.Shammas-Toma1L.De Cecco3M.Serafini3S.Cavalieri4L.Licitra4F.Hoebers5R.Brakenhoff6C.Leemans6K.Scheckenbach7T.Poli8X.Wang9X.Liu9F.Laxague1E.Prisman10C.Poh101112…A.Nichols115
Predicted Th2 Infiltrate is Associated with Outcome in HPV(-) Head and Neck Cancer.
M.K.Abdelhakiem1R.Bao2R.L.Ferris3J.Heymach4C.Pickering5J.J.Luke6H.D.Skinner1
Loss of HPV 16- E2 Predicts Disease Free Survival and Promotes Platinum Resistance in Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma
M.E.Heft-NealJ.D.SmithS.E.EllspermanA.BhangaleM.LudwigB.JewellJ.MannN.MichmerhuizenM.SpectorJ.C.Brenner
Neoadjuvant Immunoradiotherapy in a Tobacco-Signature Preclinical Oral Squamous Cell Carcinoma Model
R.Saddawi-Konefka1R.A.Msari1R.N.Jones1S.Sadat1I.Franiak-Pietryga1A.Sharabi2J.S.Gutkind3J.A.Califano4
HPV E5 Mediates Resistance to PD-1 Checkpoint Blockade Via Inhibition of MHC and IFN Pathway
S.Miyauchi1S.Kim1L.Zhang2K.Guram3R.N.Jones4J.S.Gutkind5L.K.Mell6E.Cohen7J.A.Califano8A.Sharabi1
An Artificial Intelligence Ultrasound Platform for Screening and Staging of Thyroid Cancer
R.Paul1A.Juliano2W.Faquin3A.W.Chan1
Development of a Deep Learning-Based Auto-Segmentation of Organs at Risk for Head and Neck Radiotherapy Planning
J.Koo1K.Latifi2J.J.Caudell3P.Jordan4S.Shen4P.M.Adamson4V.Feygelman2
Safety and Efficacy of RP1 + Nivolumab in Patients with Non-Melanoma Skin Cancer of the Head and Neck: Results From IGNYTE Phase 1/2 Multi-Cohort Clinical Trial
J.Niu1M.Milhem2A.M.Vanderwalde3B.Chmielowski4G.Beasley5A.Samson6J.J.Sacco7T.Bowles8T.Jew9S.He9S.Raza9K.Harrington10M.R.Middleton11
A Novel Intratumoral Microdosing Approach for Simultaneously Evaluating Multiple Drugs and Combinations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
J.Houlton1H.Cash2H.Xu2P.L.Swiecicki3S.B.Chinn4D.R.Clayburgh5R.J.Li5R.J.Christian6A.Halfpenny6A.vanZante7B.A.Hatton8K.H.W.Sottero8G.Kung8M.O.Grenley8C.Burns8E.Beirne8R.A.Klinghoffer8D.Huszar910…K.Kannan10
EAT During RT: Towards Data-Driven Goal Setting for Oral Intake Throughout RT as a Function Preservation Strategy
C.E.Barbon1C.B.Peterson2J.Reddy3A.C.Moreno3F.M.Johnson4C.D.Fuller3S.Lai5K.A.Hutcheson5
Efficacy and Safety of Tisotumab Vedotin in Patients with Head and Neck Squamous Cell Carcinoma: Results From a Phase II Cohort
D.S.Hong1A.Birnbaum2C.Steuer3M.Taylor4T.J.George5J.Lacy6B.Wang7F.Beca7L.Nicacio7I.Soumaoro8M.Cho9
Stereotactic Ablative Radiotherapy for Early-Stage Glottic Larynx Carcinoma: Results From the Phase II LT-SABR Study
D.J.SherV.AvkshtolD.T.VoD.H.MoonM.H.LinJ.DubasL.ChildsT.MauB.Sumer
Standard but Not Equal: Disparities in Advanced Radiotherapy Techniques for Head and Neck Cancer in the United States
N.S.McCall1Y.Liu2J.Janopaul-Naylor1J.E.Bates1J.S.Remick1S.Rudra1S.D.Karam3A.Amini4M.W.McDonald1W.A.Stokes1
Focal Adhesion Kinase Drives Resistance to Therapy in HPV-Negative Head and Neck Squamous Cell Carcinoma in a p53-Dependent Manner
P.Pifer1M.Kumar2L.Yang3T.Xie4M.Frederick5A.Hefner6B.M.Beadle7A.Dhawan6D.Molkentine8J.Molkentine8J.N.Myers9C.Pickering10J.Heymach11H.D.Skinner12
Institutional Comparison between Radiation with Concurrent Cisplatin Versus Carboplatin/paclitaxel for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
M.Abousaud1M.Shepherd2F.Lozano2B.Fowowe2Y.Cao3S.Rudra4W.A.Stokes4N.C.Schmitt5M.W.El-Deiry6M.R.Patel7C.Steuer8D.M.Shin9Y.Liu10N.F.Saba9
Analysis of Outcomes by Smoking Status in a Phase III Trial of De-Escalated Adjuvant Chemoradiation Therapy in Human Papillomavirus (HPV(+)) Oropharyngeal Squamous Cell Carcinoma (OPSCC)
P.W.McGarrah1D.M.Routman2D.J.Ma2K.Van Abel3E.J.Moore3S.H.Patel4M.L.Hinni5B.Fruth6N.R.Foster6L.X.Yin3M.A.Neben-Wittich2Y.Garces2L.A.McGee4J.C.Rwigema4D.L.Price3J.R.Janus7A.V.Chintakuntlawar1P.Savvides8…K.Price1
A Prospective Study of Mucosal Sparing Proton Beam Therapy in Resected Oropharyngeal Cancer Patients
S.H.Patel1D.J.Ma2T.H.Nagel3E.J.Moore4J.C.Rwigema1M.A.Neben-Wittich2L.A.McGee1R.E.Hayden3R.L.Foote5L.R.Crujido3T.A.DeWees6M.A.Golafshar6A.Anand1M.Y.Halyard1M.L.Hinni7
Omission of the Pathologic Node-Negative Neck From Postoperative Radiation Therapy for Oral Cavity Cancer
J.Hara1N.S.Ecanow2S.Uddin3A.J.Rosenberg4A.Pearson5D.Chan6E.A.Blair6N.Agrawal7N.Cipriani8M.Lingen8E.E.Vokes5Z.Gooi6D.J.Haraf1A.Juloori1
Management of Positive Main Specimen Margin in Oral Tongue Cancer
R.T.Judd1L.Zhang1S.Zhao1C.Rygalski1M.M.Li2B.Swendseid1D.M.Blakaj3A.Agrawal2E.Ozer2R.Carrau2T.Teknos4K.VanKoevering5J.W.Rocco4M.Old6N.Seim7C.T.Haring1S.Kang6
Adjuvant Oropharynx Cancer Management in the Era of Tors and HPV: A Recursive Partitioning Analysis
J.Janopaul-Naylor1M.Rupji2J.Lorenz1J.Switchenko2J.E.Bates1M.W.McDonald1D.M.Shin3B.J.Boyce4W.A.Stokes1
Optimal Threshold of Neutrophil-Lymphocyte Ratio and its Association with Survival Outcome Among Patients with Head and Neck Cancer in the United States
S.J.Ma1M.Khan2J.Gill3S.Santhosh2U.Chatterjee1A.J.Iovoli1M.K.Farrugia1K.E.Wooten1V.Gupta4R.Mcspadden1H.Yu1M.Kuriakose1M.Markiewicz3W.L.Hicks1M.E.Platek5M.Seshadri1A.D.Ray1E.Repasky1A.K.Singh1
Does Operability Status Influence Outcomes in Patients with T4 Larynx Cancer Undergoing Larynx Preservation?
A.Schlafstein1S.Goyal2A.Amini3S.D.Karam4N.F.Saba5A.S.Kaka6A.H.Aiken7J.J.Beitler8W.A.Stokes8
Predictors of Occult Nodal Involvement in Clinically Node Negative Primary Parotid Carcinoma: An NCDB Analysis
J.Lorenz1Y.Liu2S.Goyal3J.S.Remick1S.Rudra4S.Hanasoge1D.S.Yu15C.Steuer6W.A.Stokes1
Elective Neck Treatment for Clinically Node-Negative Salivary Gland Cancer: Observation, Neck Dissection, or Neck Irradiation?
E.Ilori1B.Hair2L.Rybicki3B.B.Burkey4J.L.Geiger5E.Lamarre4B.Prendes4J.Ku4D.Chute6C.Griffith6N.M.Woody1S.Koyfman1S.R.Campbell1
Have We Made Progress in Early Stage Vocal Cord Cancer with Impaired Cord Mobility?
A.N.De Leo1R.Dagan2C.G.Morris1A.L.Holtzman2K.E.Hitchcock1C.M.Bryant2R.J.Amdur1W.M.Mendenhall1
The Number of Radiographically Positive Lymph Nodes is Predictive of Survival in HPV-Associated Oropharyngeal Cancer and Further Stratifies Outcomes Beyond Clinical Staging Alone
R.O.Kowalchuk1K.Van Abel2A.Sauer2L.X.Yin3J.J.Garcia4W.S.Harmsen5E.J.Moore2D.L.Price3A.V.Chintakuntlawar6K.A.Price7S.C.Lester1M.A.Neben-Wittich1S.H.Patel8R.L.Foote9D.J.Ma1A.A.Nagelschneider10D.M.Routman1
Utility of Intermediate Risk Volumes in Human Papilloma Associated Oropharyngeal Cancer: A Pattern of Failure Analysis
G.Q.Yang1M.Echevarria2J.J.Caudell3
Acute Toxicity Profile and Early Efficacy Results of De-Escalated, Risk-Directed Post-Operative Adjuvant Therapy for Human Papillomavirus-Positive Oropharynx Squamous-Cell Carcinoma: A Phase 2 Trial
Z.Jose1W.L.Thorstad2R.S.Jackson1P.Oppelt3J.Ley4M.D.Daly2R.C.Paniello1P.Pipkorn1J.Rich5S.Puram6J.Liu7H.A.Gay8M.Jacobs9D.Adkins10
Trilynx: A Phase 3 Trial of Xevinapant and Concurrent Chemoradiotherapy (CRT) for Locally Advanced Head and Neck Cancer
J.D.Schoenfeld1E.Cohen2C.M.Nutting34L.Licitra5B.Burtness67M.Omar8F.Bouisset8H.Nauwelaerts8Y.Urfer8C.Zanna8J. BourhisSr9
EVOLVE: Evaluating the Safety of De-escalated Head and Neck Irradiation in HPV Positive Oropharynx Cancer in Non/Minimal Smokers.
M.J.Blanchard1A.Terrell2R.Vegunta1S.Powell3R.K.Nowak4D.Almquist1A.Schmidt1B.Bloch1K.Shafique2L.Geeraerts1S.R.W.Nurkic1A.W.Jensen1C.Ellison5W.Spanos3
Brain Global Structural and Network Topological Alterations in Long-term Nasopharyngeal Cancer Survivors
R.PaulA.W.Chan
Association of Body Mass Index with Survival Outcome in Patients with Head and Neck Cancer Treated with Combined Modality Therapy
S.J.Ma1M.Khan2A.J.Iovoli1M.K.Farrugia1K.E.Wooten1V.Gupta3R.Mcspadden1M.Kuriakose1W.L.Hicks1M.E.Platek4A.K.Singh1
Outcomes of Patients With Adenosquamous Carcinoma of the Head and Neck after Definitive Treatment
D.S.Buchberger1S.R.Campbell1S.Wu2E.Lamarre3B.Prendes3J.Ku3J.Scharpf3R.R.Lorenz3N.Silver3C.Griffith4J.L.Geiger5E.Yilmaz5S.Koyfman1N.M.Woody1
Factors Predictive of Primary Therapeutic Modality in Early-Stage Oropharyngeal Squamous Cell Carcinoma
J.E.Bates1W.A.Stokes1J.S.Remick1S.Rudra1M.W.McDonald1C.Steuer2D.M.Shin3A.S.Kaka4N.F.Saba2M.R.Patel4
Optimal Threshold of Pre-Treatment Hemoglobin Level as a Prognostic Biomarker for Survival Outcome in Patients with Head and Neck Cancer in the Era of Human Papillomavirus
S.J.Ma1M.Khan2J.Gill3S.Santhosh2U.Chatterjee1A.J.Iovoli1M.K.Farrugia1K.E.Wooten1V.Gupta4R.Mcspadden1H.Yu1M.Kuriakose1M.Markiewicz3W.L.Hicks1M.E.Platek5M.Seshadri1A.D.Ray1E.Repasky1A.K.Singh1
DEHART: Dose-Escalated Hypofractionated Adaptive Radiation Therapy with Atezolizumab for Head and Neck Cancers
M.J.Awan1S.Tarima2J.Zenga2E.S.Paulson1C.J.Schultz2M.E.Shukla3S.Firat2A.Shreenivas2B.Campbell2B.Massey2M.Stadler2M.Agarwal2S.Wong2
Locoregional Recurrence Trends in Head and Neck Cutaneous Squamous Cell Carcinoma
A.J.JonesK.N.PowellM.G.MooreA.MantravadiM.SimJ.Yesensky
Dosimetric Comparison of Intensity Modulated Radiotherapy (IMRT) and Intensity Modulated Proton Therapy (IMPT) for Novel Oral Tongue Avoidance Concept in Low-Risk Squamous Cell Carcinoma of the Oral Tongue
R.H.Press12L.Hu1S.Huang1S.Hasan1I.J.Choi13C.B.SimoneII13A.M.Chhabra12D.Gelblum3R.Kabarriti4S.Sharma2R.L.Bakst2J.Cracchiolo5S.M.McBride3N.Y.Lee3
Treatment Implications for Complete Pathologic Responders to Neoadjuvant Immunotherapy
M.Fiorella1Z.Elliott1J.Johnson23J.M.Curry34D.Cognetti13R.Axelrod23V. BarAd35A.Luginbuhl16
Neoadjuvant QUAD Shot as Temporizing Measure Prior to Definitive Surgery for Locally Advanced Oral Cavity Cancer
M.L.Truong1M.L.Hsieh1C.Henson1G.A.Krempl2
Organ Preservation with Definitive Chemoradiotherapy for T4 Laryngeal Squamous Cell Carcinoma
J.Hara1N.S.Ecanow2A.J.Rosenberg3A.Pearson4S.Kochanny5Z.Gooi6B.J.Baird6E.A.Blair6N.Agrawal7E.E.Vokes4D.J.Haraf1A.Juloori1
Induction Chemotherapy with Cisplatin, Paclitaxel, and Capecitabine (PTC) in Locally Advanced (LA) Squamous Cell Carcinoma of Head and Neck (SCCHN)
J.F.Alvarado-Muñoz1A.Reyes-Morales1V.Puac-Polanco2G.Bruixola3M.Chivalan1S.Torselli1
Total Number of Lymph Nodes in Neck Dissection and its Relation to Cancer-Positive Lymph Nodes as a Prognostic Indicator in Aerodigestive Tract Cancers
M.A.Nujoom1H.Z.Marzouki1R.K.Al-Wassia23
The Impact of Head and Neck Multidisciplinary Clinic on Treatment Package Time During the COVID-19 Pandemic: A Single Institutional Experience
S.Khaja1C.T.Wilke2
Prognostic Significance of Referral Patterns and Time Trends in Head and Neck Cancer Management
D.Balchander1D.Hoying2C.I.Cabrera1K.Shorbaji1K.Clancy1N.Fowler1J.E.Thuener1P.Lavertu1T.N.Teknos3R.P.Rezaee1S.Li1A.Tamaki1
Genetic Ancestry and Variants Correlate with the Risk of HPV Oral Infection in Adult Healthy Men
J.Deeken1P.Kothiyal2H.Wang3G.Jo2S.Hazrati2E.McNair2R.Iyer2G.L.Maxwell2
The Effects of the COVID-19 Pandemic on Cancer Staging in Patients Diagnosed With Head and Neck Cancer at an Academic Health Center
D.Mack1H.Spencer1K.Wang2G.D.Lewis3
Access to Care for Head and Neck Cancer Patients: The Influence of Expanded Medicaid in Louisiana
M.Noonan1J.Pang1T.Li2M.A.N.Bhuiyan1C.A.O.Nathan1M.T.Yim1
Head and Neck Cancer Incidence and Trends Differ by Site, Race, and Sex
A.Mazul1S.Chidambaram12S.Massa2
Temporal Trends in Oropharyngeal Cancer Incidence, Survival, and Cancer-Directed Surgery Among Elderly Americans
S.Chidambaram1S.Hong1M.C.Simpson1N.Osazuwa-Peters2G.M.Ward3S.Massa1
The Medicare Effect on Head and Neck Cancer Diagnosis and Survival
J.B.Smith1S.Hong1R.Jayanth2M.C.Simpson1S.Massa1
Association Between Glycosyltransferase Expression and Survival in Head and Neck Cancer
B.Montesino1N.Hu2J.M.Lozano3R.Sackstein1K.B.Chandler1
Imaging Radiomic Biomarkers of Mandibular Osteoradionecrosis for Head and Neck Cancer
A.S.Mohamed1A.Abusaif2A.Moawad2L.V.van Dijk1D.Fuentes3K.Elsayes2C.D.Fuller1S.Lai4
Auto-Segmentation of Oropharyngeal Cancer Primary Tumors Using Multiparametric MRI-Based Deep Learning
K.A.Wahid1S.Ahmed1R.He1L.V.van Dijk1J.Teuwen2B.McDonald1V.Salama1A.S.Mohamed1T.Salzillo1C.Dede1N.Taku1S.Lai3C.D.Fuller1M.Naser1
Diagnostic Accuracy of FNA to Determine HPV Status in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
R.Morse1B.Beaty2L.Scanga3J.Blumberg4S.Patel5C.Shen1B.S.Chera1
Identification of Extracapsular Extension in Head and Neck Cancer Patients Using Artificial Intelligence.
Y.Wang1T. VengaloorThomas2W.N.Duggar2P.R.Roberts2R.T.Gatewood3L.Bian1H.Wang1
Changes in Organs at Risk Dose Estimates Due to Anatomic Changes and Registration Method During Head and Neck Radiotherapy and its Relationship to Percent Weight Loss
A.Z.DiazP.D.SoniS.P.Srivastava
PET/CT Prediction of Head and Neck Melanoma Nodal Metastases
J.L.Farlow1S.Moorman1N.S.Peddireddy1K.K.Wong1C.L.Stucken2
Novel VMAT Planning Technique Improves Dosimetry for Head and Neck Cancer Patients Undergoing Definitive Chemoradiotherapy
D.DiBartoloT.J.CarpenterJ.P.SantoroD.W.EblingJ.A.HaasJ.W.LischalkM.R.WittenM.RybsteinA.E.VaeziM.C.Repka
Prospective Study of PET/MRI Tumor Response During Chemoradiotherapy for Patients with Low and Intermediate Risk p16-positive Oropharynx Cancers
M.E.Witek1A.Burr2G.Avey3J.Y.Bruce4T.Chandereng5R.J.Kimple2J.BrowerJr6P.M.HarariJr7
Pathologic Comparison of Locally Advanced p16-Negative and p16-Positive Larynx Squamous Cell Carcinoma
J.D.Cohen1P.Dontu2K.Hatten3R.Mehra4J.Wolf5R.Taylor6J.Papadimitriou7M.E.Witek8
Contemporary Radiotherapy for Fisch-Classified Jugulotympanic Paragangliomas - Does Tumor Category Matter? Outcomes From a 13-Year Experience
F.L.Ampil1A.Sin1C.A.O.Nathan2D.Smith1G.Mankekar1
Impact of Routine Surveillance Imaging on Detecting Recurrence in Sinonasal Malignancies
K.King1S.Roy1R.Rauch2P.Escobedo2M.Bhayani1N.P.Joshi1
IMRT Head and Neck Cancer Treatment Plans with a Novel Fast Ring-Gantry Radiotherapy System
O.M.OderindeD.SeelyS.M.Shirvani
Differential Activation of Cancer-Associated Fibroblasts in HPV-Associated Head and Neck Squamous Cell Carcinoma Patients Detected Using Spatial Transcriptomics
S.Sussman1A.Linnenbach2L.Harshyne3A.South4G.Kumar5A.Alnemri6Z.Urdang7L.Anderson-Pullinger8M.Mahoney4A.Argiris8J.Johnson9A.Luginbuhl10U.Martinez-Outschoorn9J.M.Curry11
Phase 1/2 Study of Pepinemab in Combination with Pembrolizumab as First-Line Treatment of Advanced, Recurrent or Metastatic Head and Neck Cancer (KEYNOTE B84)
T.L.Fisher1E.E.Evans1C.Mallow1A.Foster1M.Boise1E.Smith1J.E.Leonard1M.Chaney2J.T.Beck3S.Hager4N.F.Saba5C.Steuer5D.Adkins6B.Burtness7M.Zauderer1
A Phase 2/3, Randomized, Open-Label Study of Bempegaldesleukin Plus Pembrolizumab vs. Pembrolizumab Alone in First-Line Treatment of Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma with PD-L1-Expressing Tumors (PROPEL-36)
T.Y.Seiwert1R.I.Haddad2D.Johnson3M.Gillison4U.Keilholz5M.Tahara6J.P.Machiels7J.Deeken8V.Villaflor9Y.Su10T.Guthrie11D.M.Shin12K.De Block13A.Meirovitz14D.Chien15M.Tagliaferri15J.Zalvesky15K.Harrington16
Lachnoclostridium and Immune Inflamed Gene Expression Signature Association in Head & Neck Cancers
E.Yilmaz1A.Yalamanchali2M.E.Dwidar3J.L.Geiger1S.Koyfman4T.A.Chan4N.Silver5
Preliminary Safety of PDS0101 (Versamune +HPVmix) and Pembrolizumab Combination Therapy in Subjects with Recurrent/Metastatic Human Papillomavirus-16 Positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)
L.Wood1A.V.Chintakuntlawar2K.Price2J.Kaczmar3G.Conn1F.K.Bedu-Addo1J.Weiss4
Impact of Tobacco, Marijuana and Alcohol Use on Overall Survival in Recurrent Metastatic Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors
M.Issa1M.Husain1B.Klamer2G.Laliotis3N.Mladkova4V.Karivedu1P.Bhateja1K.Dibs4J.Pan2J.C.Grecula4S.R.Jhawar4M.Old1D.L.Mitchell4S.Baliga4R.Carrau5J.W.Rocco6D.M.Blakaj4M.Bonomi1
Immunotherapy Response in Cutaneous Squamous Cell Carcinoma Patients with Cranial Nerve Involvement
N.Lopetegui1D.Dima1D.S.Buchberger2L.Roof1R.R.Lorenz3B.Prendes3J.Ku3E.Lamarre3J.Scharpf3N.L.Silver3L.Schwartzman4J.L.Geiger1N.M.Woody2S.R.Campbell2S.Koyfman2E.Yilmaz1
Role of TMB and PD-L1 as Prognostic Factors and Predictors of Response to Immunotherapy in Head and Neck Squamous Cell Cancer
M.Porosnicu1K.Burcher1J.W.Lantz2E.Gavrila1J.T.Burcher3R.T.Hughes4T.Lycan5P.M.Bunch6W.Zhang7R.D'AgostinoJr8
Immunotherapy Response in Patients with Pre-Existing Autoimmune Disorders and Head and Neck Cancers
C.Y.Han1C.W.R.Fitzgerald2J.Cevallos3M.Lee4C.Valero2L.G.Morris2
Outcomes Following Immunotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Single-Institution Experience
A.Yalamanchali1K.Yang2L.Schwartzman3S.R.Campbell2N.L.Silver4N.M.Woody2C.Griffith5V.Cracolici5D.Chute5S.Koyfman2J.L.Geiger6E.Yilmaz6
Role of Tertiary Lymphoid Structures and Immunotherapy in Head & Neck Squamous Cell Carcinoma
P.Hannikainen1A.Luginbuhl2
Patterns of Failure and Cost Analysis for Integrating a Novel Tumor HPV DNA Assay Into HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+OPSCC) Recurrence Surveillance
M.Lin1C.McLaughlin2J.Garneau3P.W.Read4
Stereotactic Body Radiation Therapy (SBRT) Following Salvage Surgery for Previously Irradiated Head and Neck Cancer
A.Lee1X.A.Wang2H.Wang2A.C.Moreno1J.Reddy1M.T.Spiotto1G.B.Gunn1D.I.Rosenthal1C.D.Fuller1W.H.Morrison1S.J.Frank1R.Ferrarotto3N.D.Gross4R.P.Goepfert4A.M.Gillenwater4A.C.Hessel4S.Y.Su4E.Y.Hanna4…J.Phan1
Quad-Shot Radiotherapy in Combination with Immune Checkpoint Inhibition for Advanced/Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Single-Arm Pilot Study
R.T.Hughes1T.Lycan2P.M.Bunch3K.M.Greven1B.A.Frizzell1C.M.Furdui4R.D'AgostinoJr5P.Triozzi2W.Zhang6M.Porosnicu2
Real-World Patient Characteristics and Time on Treatment Outcomes Among Patients Receiving First-Line Pembrolizumab in the Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the United States
L.WangC.BlackK.RamakrishnanV.Turzhitsky
A Phase 2 Study of Magrolimab Combination Therapy in Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
A.D.Colevas1J.J.Park2B.Fang3J.Shao4L.U'Ren4J.Odegard4I.Lal4M.Phan5K.Z.Thein6D.Adkins7
Post-Operative Hypothyroidism Predicts Fistula Development Following Salvage Oropharyngectomy
A.Prince1Z.Huttinger2M.E.Heft-Neal1J.R.Brennan3S.B.Chinn4K.Malloy4C.L.Stucken4K.Casper4M.E.Prince4M.Spector1A.J.Rosko4
Phase 2 LEAP-009: Lenvatinib (Lenva) With or Without Pembrolizumab (Pembro) vs. Chemotherapy (Chemo) for Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That has Progressed on Platinum and Immunotherapy
K.Harrington1E.Cohen2L.Siu3D.Rischin4L.Licitra5J.Vermorken6Q.T.Le7M.Tahara8J.P.Machiels9N.Hawk10J.Ge11B.Bidadi11R.Swaby11B.Burtness12
Clinical Variables Associated with Survival and Treatment Response in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
C.T.Haring1L.Kana2S.Dermody1J.D.Smith1J.C.Brenner1K.Casper1S.B.Chinn1K.Malloy1M.L.Mierzwa3M.E.Prince1A.J.Rosko1C.Schonewolf3J.L.Shah3C.L.Stucken1A.Shuman1M.Spector4F.Worden4P.L.Swiecicki5
Stereotactic Ablative Radiotherapy for Dural Recurrence of Esthesioneuroblastoma
C.D.Goodman1H.Wang2K.Diao1F.DeMonte3A.S.Garden1E.Y.Hanna4A.Lee1A.C.Moreno1S.M.Raza5J.P.Reddy6D.I.Rosenthal1M.Spiotto1S.Y.Su4J.Phan1
Immune and Tumor Genome Signatures Associated with Response to Radiotherapy and Chk-1 Inhibition in a Phase 1b Clinical Trial for Patients with Head and Neck Squamous Cell Carcinoma
C.A.Clark1D.della Manna2L.Nabell3C.D.Willey2J.A.Bonner2M.C.Dobelbower2S.A.Spencer2E.S.Yang2
Evaluating the Therapeutic Potential of a Small Molecule ATR Inhibitor Combined with Radiotherapy for Head and Neck Squamous Cell Carcinoma
D.OdhiamboA.M.BassilR.CastilloD.G.KirschY.M.Mowery
HPV16-A1 Genotype is Associated with Poor Recurrence-Free Survival in HPV16 Associated Squamous Cell Carcinoma of the Oropharynx
T.P.Schrank1L.Landess2W.H.Stepp3H.Rehmani2W.Weir2N.Lenze4A.Lal2S.Jefferys2J.Blumberg2S.Patel1C.Lumley1T.Hackman1N.Issaeva1W.Yarbrough1
Decreased Expression of PTENP1 by Smoking Induces Drug Resistance Through c-MYC Activation in HPV+ Oropharyngeal Squamous Cell Carcinoma
Z.Liu1Z.Jose2
Detection of Locoregional Minimal Residual Disease Immediately After Surgery Through Multi-Omic Analysis of Tumor-Associated Cell-Free DNA in Surgical Drain Fluid
N.Earland1R.J.Ramirez1P.K.Harris2S.Gerndt1Z.Xu3A.Hearn3J.Szymanski2N.Semenkovich4S.Jasim3A.A.Chaudhuri2
Stable Reconstitution of Gasdermin-E in a Gasdermin-E-Deficient Head and Neck Squamous Cell Carcinoma Mouse Cell Line Enhances Pyroptosis-Mediated Release of Tumor Immunogenic Molecules
A.Alnemri1S.Wang2M.Wang3M.Domingo-Vidal4A.Linnenbach5U.Martinez-Outschoorn4T.F.Alnemri3E.S.Alnemri3J.M.Curry1
Antitumor Activity of Tipifarnib and PI3K Pathway Inhibitor in HRAS-associated HNSCC
A.Smith1S.Chan1A.McCloskey1H.Vora1F.Burrows2S.Malik1
A Phase 0 Master Protocol Utilizing a Novel Intratumoral Microdosing Approach for Simultaneously Evaluating Multiple Drugs and Drug Combinations in Patients with Solid Tumors
T.J.Ow12V.Mehta1A.J.Gersten2J.G.Newman3R.G.Maki4K.R.Gundle5D.R.Clayburgh6R.J.Li6M.Porosnicu7C.A.O.Nathan8B.A.Hatton9K.H.W.Sottero9G.Kung9M.O.Grenley9K.Anderson9R.A.Klinghoffer9
Targeting PI3Kα/δ and the ErbB Family of Protein-Tyrosine Kinases in Cisplatin-Resistant Head and Neck Squamous Cell Carcinomas
X.Geng1Z.Yang1J.Liao1N.Mirkheshti2R.Mehra3K.J.Cullen4H.Dan1
Nomogram Using Host and Tumor Factors to Predict Survival in Individual Patients with Well Differentiated Thyroid Cancer
C.Valero1A.Yuan2D.Matsuura2D.Adilbay2M.McGill2V.Harries2A.Shaha1J.Shah1R.M.Tuttle2S.Patel1I.Ganly1
Head and Neck Sweat Gland Carcinomas: Clinical Characteristics and Patterns of Care
A.J.Gordon1A.Patel1F.Zhou2A.Jacobson3M.Tam4B.Givi3
Tall Cell Histology – Comparison of T1 Tall Cell Variant and Classical Papillary Thyroid Carcinoma
R.S.R.Woods1C.W.R.Fitzgerald1C.Valero1J.Lopez1L.G.Morris1M.Cohen1R.J.Wong1S.Patel1R.A.Ghossein2R.M.Tuttle3A.Shaha1J.Shah1I.Ganly1
Adoption of Adjuvant Chemotherapy in High-Risk Salivary Gland Malignancies
A.Patel1A.J.Gordon1M.Tam2B.Givi3
The Value of Online CME in the Multidisciplinary Care of Patients with NTRK Fusion-Positive Thyroid Cancer
M.A.Worst1A.Carothers1M.Surducan1J.Sipos2L.Wirth3
Outcomes and Prognostic Factors in Acinic Cell Carcinoma of the Parotid Gland: Mature Results From a Single Institution
P.E.Romine1J.Voutsinas2Q.Wu3M.Tratt1J.J.Liao4U.Parvathaneni4B.Barber1J.Dillon1M.A.Timoshchuk5N.Futran6J.Houlton6G.E.Laramore1R.G.Martins1K.D.Eaton1C.P.Rodriguez7
The Role of Surgery in Small Differentiated Thyroid Cancer
F.Baidoun1Z.Merjaneh1O.Abdel-Rahman2
Neuroendocrine Neoplasms of the Oropharynx—A Literature Review
L.Maciejko1V.Palacios2K.Van Abel3T.Halfdanarson4A.V.Chintakuntlawar5P.W.McGarrah5K.Tasche3
Speech and Swallowing Function Following De-Escalation Adjuvant Chemoradiotherapy or Standard of Care Adjuvant Therapy for HPV Associated Oropharyngeal Carcinoma: A Prospective Randomized Trial
K.Van Abel1K.Price2E.J.Moore1S.H.Patel3M.L.Hinni4B.Fruth5N.R.Foster5L.X.Yin6M.A.Neben-Wittich7L.A.McGee3J.C.Rwigema8D.M.Routman7S.C.Lester7D.L.Price6J.R.Janus9T.H.Nagel4A.V.Chintakuntlawar2P.Savvides10…D.J.Ma11
Randomized Phase III, Double Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma
A.E.Cook1A.Modh2H.Ali3J.Sheqwara3S.Chang4T.Ghanem4S.Momin4V.Wu4S.Tam4S.Money5X.Han6L.Fakhoury1B.Movsas1F.Siddiqui1
Defining the Psychiatric and Financial Landscape of Mental and Substance Use Disorders in Head and Neck Cancer Patients
S.Baliga1B.Klamer2J.D.Palmer3S.Wells4M.E.Gamez3S.R.Jhawar5D.L.Mitchell3J.C.Grecula3S.Kang4N.Seim6E.Ozer7A.Agrawal7K.VanKoevering8V.Karivedu4P.Bhateja4M.Bonomi4M.Old4J.W.Rocco9…D.M.Blakaj10
Budget Impact of Keytruda for the Treatment of Patients with Recurrent or Metastatic (R/M) and Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC) in the United States
X.J.Li1D.Muston1K.Ramakrishnan1C.Black1R.Hughes2G.Weston2S.Lucherini2
30-Day Morbidity and Bleeding Rates Associated with Transoral Robotic Surgery for HPV Associated Oropharyngeal Squamous Cell Carcinoma: A Retrospective Analysis of Two Prospective Adjuvant Radiotherapy Deescalation Trials (MC1273 & MC1675)
T.J.Haller1T.J.O'Byrne1E.J.Moore2D.J.Ma3K.A.Price4S.H.Patel5M.L.Hinni6M.A.Neben-Wittich7L.A.McGee5D.L.Price8J.R.Janus9J.L.Kasperbauer8T.H.Nagel6A.V.Chintakuntlawar10P.Savvides11J.J.Garcia12R.L.Foote3K.Van Abel2
Treatment of Radiation-Induced Xerostomia with INF-g Pre-Licensed Mesenchymal Stromal Cells (MSCs)
C.Paz1G.C.Blitzer2A.Glassey3J.Giri1A.Pennati1O.Ganz1S.Schreiber1K.P.Nickel1C.Kelm-Nelson1C.Vanessa1R.Pohlman1T.Glazer1T.Lunga3D.Robbins3R.Mattison1T.Varghese1S.Thibeault3N.Pulia1…R.J.Kimple2
Effects of Head and Neck Cancer Diagnosis and Treatment on Patient-Partner Intimacy
M.Fiorella1A.Koka2A.Alnemri3S.Sussman1B.Worster4A.Leader56A.Luginbuhl16
Long Term Results of a Longitudinal Study of Unmet Survivorship Needs in Patients with Head and Neck Cancer
I.Busca1M.E.Giuliani1J.Weiss1J.Jones2N.K.Quartey3S.H.Huang1A.Toulany4J.Papadakos3J.G.Ringash1
Post-Treatment Evaluation of Swallowing Function Using Quantitative Videofluoroscopy in Head and Neck Patients Undergoing Immunoradiotherapy or Chemoradiotherapy
H.C.Liu1L.Vitzthum2C.W.Williamson1L.M.Hill3J.Zou4T.J.Nelson1B.Faung1K.Linnemeyer5J.R.Todd1A.Sacco6P.Sanghvi1A.Sharabi1J.A.Califano5L.Blumenfeld5L.K.Mell1
The Affects of Adjuvant Radiotherapy on Survival in Elderly Patients with Advanced Head & Neck Squamous Cell Carcinoma
J.M.Butkus1M.Crippen2A.Luginbuhl3
Unilateral vs. Bilateral Radiotherapy for Oropharyngeal Carcinoma: Impact on Long Term Symptom Burden
I.Busca1J.de Almeida2S.H.Huang1J.Su3W.Xu3M.Li3S.V.Bratman1J.Cho1M.E.Giuliani1E.Hahn1A.J.Hope1J.Kim1B.O'Sullivan1J.G.Ringash1J.Waldron1A.Hosni1
Effectiveness of Gabapentin in Reducing Opioid Requirements after Radiation in Head and Neck Cancer in a Single Institution
D.Gilley1A.Clark2M.Wieser3C.Bollig4L.Dooley5G.Biedermann6
Risk of Osteoradionecrosis in Reconstructed vs.Native Mandibles in Oral Cavity Cancer Following Intensity-Modulated Radiotherapy
S.Wu1E.Lamarre2M.Fritz3J.Ku2C.A.Reddy4P.Brauer5N.M.Woody4S.R.Campbell4S.Koyfman4
Observations on Carotid Artery Stenosis Following Neck Irradiation
B.A.Harr1R.M.Kahnert2C.A.Reddy1S.Fryberger1M.Fox1J.Ferrini3D.Ives3S.R.Campbell1E.Yilmaz3L.Schwartzman3N.M.Woody1J.L.Geiger3S.Koyfman1J.Bodmann3
Patient-Reported Outcomes in Head and Neck Cancer: A Systematic Review of Clinical Trials
A.C.Cao1J.S.Lu2S.B.Hobday1E.Cohen3L.Sun4J.N.Lukens5R.Brody3
Cannabis Use in Patients with Head and Neck Cancer and Radiotherapy Outcomes
A.M.Williams1M.Gilbert2F.Siddiqui2
Health Insurance Literacy in Head and Neck Cancer Patients
K.Patel1R.McCormick1L.Kim2A.Otto3A. AlishahiTabriz1Y.R.Hong4J.W.Rocco5A.Nichols6X.Wang1H.Jim1M.Reblin7K.Turner1
Does Cetuximab Reduce the Risk of Anemia in Patients Undergoing Radiation Therapy for Head and Neck Cancers?
A.I.Ghanem12L.Maahs3R.Gutta3A.Tang4M.Gilbert1S.Arya3Z.A.Saheli3S.Tam5J.Sheqwara6F.Siddiqui1
Predictive Value of Health-Related Quality of Life on Radiotherapy Related Toxicities in Patients with Head and Neck Cancer
O.Billa1F.Bonnetain2J.Chamois3A.Ligey4V.Ganansia5S.Renard6M.Quivrin7P.Truntzer5N.Vulquin7G.Noel5P.Maingon8S.T.Dabakuyo-Yonli1
Impact of a Head and Neck Cancer Chemoradiation (HNC CRT) Nurse Practitioner (NP) on Patient Outcomes
A.McCready1M.Quinn1P.Francis1R.Stortz1S.Kuruvilla12P.Stewart12D.A.Palma12P.Lang12N.E.Read12J.Sathya12V.M.Venkatesan12A.Nichols13D.MacNeil13K.Fung13A.Mendez13C.Carreau1S.Hawkins1C.Parker1…E.Winquist12
The Impact of Nasogastric Feeding Tube on Physiologic Swallow in Head and Neck Cancer Patients: A Multidisciplinary Clinical Trial
M.N.Stevens1E.Hosokawa2A.Hereford2M.West2R.Fleming2K.Sharif3R.Sinard2S.L.Rohde2K.Mannion2A.Langerman2J.Netterville2E.L.Rosenthal2M.C.Topf2
Incidence of Deep Venous Thrombosis (DVT) in Head and Neck Cancer Patients Receiving IV Fluids (IVF) via Peripheral IV (PIV) Compared to Central Venous Catheter
S.Wing1B.Cham2M.Khan3M.Ploch3S.Reyes3S.Jafri4A.Blanco3
Marrow Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study Protocol for a Phase I Dose Escalation Trial of Patients with Xerostomia after Radiation Therapy for Head and Neck Cancer
G.C.Blitzer1N.Pulia2R.Mattison2T.Varghese2O.Ganz2R.J.Chappell2J.Gallipeau2K.McDowell2R.Meyers2T.Glazer2R.J.Kimple1
Predictive Molecular Biomarkers for HPV-Associated Head and Neck Squamous Cell Carcinoma
W.Yarbrough1T.P.Schrank1J.Blumberg1S.Patel1T.Hackman1C.Lumley1B.Burtness2N.Issaeva1
Evaluation of Cell-Free HPV DNA in Patients With HPV-Associated Oropharyngeal Cancer Treated With Induction Chemotherapy and Response-Adaptive Therapy
A.J.Rosenberg1H.Sloane2R.Hasina3K.Schmitt2E.Gramiccioni2J.Fredebohm4F.Jones2E.Izumchenko1N.Agrawal3
Diagnostic Value of Hormonal Receptor Evaluation in Salivary Duct Adenocarcinoma
S.Shikdar1E.Fowle2H.Razaq3W.Razaq4
